FDA Import Refusal 1FX-3503980-0/20002/2 — Cipla Limited
The FDA refused shipment 1FX-3503980-0/20002/2 from Cipla Limited (India) on Sep 25, 2026. The refused product falls under Drugs and Biologics — RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 25, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60SCA27 RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER)
- Charges
- 75